Preparing service availability
Loading related services
Lahalak Medical PlatformDifferentiate Care
Quantitative PCR for CBFB/MYH11 inv(16) Rearrangement
An advanced molecular assay used for diagnosing Acute Myeloid Leukemia (AML) and monitoring treatment response with high precision, enabling early detection of minimal residual disease (MRD).
A quantitative molecular test detecting the CBFB/MYH11 gene rearrangement. It is essential for leukemia classification and monitoring minimal residual disease to ensure effective treatment and prevent relapse.
Short answers to the FAQs published with this service.
Reference material and files associated with this service when available.
Each provider has one service price, then you choose from its available branches.
Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.
We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.
Related services
